INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,458 | -22.5% | 7,320 | 0.0% | 0.05% | -23.5% |
| Q2 2023 | $298,510 | +9.4% | 7,320 | 0.0% | 0.07% | -1.4% |
| Q1 2023 | $272,816 | +13.0% | 7,320 | +5.8% | 0.07% | -12.7% |
| Q4 2022 | $241,439 | -37.6% | 6,920 | 0.0% | 0.08% | -39.2% |
| Q3 2022 | $387,000 | +8.1% | 6,920 | 0.0% | 0.13% | +12.1% |
| Q2 2022 | $358,000 | -12.9% | 6,920 | +22.3% | 0.12% | -4.1% |
| Q1 2022 | $411,000 | -38.6% | 5,660 | 0.0% | 0.12% | -37.3% |
| Q4 2021 | $669,000 | -11.9% | 5,660 | 0.0% | 0.19% | -22.2% |
| Q3 2021 | $759,000 | -17.1% | 5,660 | 0.0% | 0.25% | -18.7% |
| Q2 2021 | $916,000 | +101.8% | 5,660 | 0.0% | 0.30% | +69.4% |
| Q1 2021 | $454,000 | +48.9% | 5,660 | +1.1% | 0.18% | +20.8% |
| Q4 2020 | $305,000 | – | 5,601 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |